Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Study to Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With Relapsed or Refractory B-precursor Acute Lymphoblastic Leukemia(ALL)

NCT03123887 is registered in ClinicalTrials.gov with Harbin Hematology and Oncology Institute as lead sponsor.

NCT NCT03123887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03123887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Study to Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With Relapsed or Refractory B-precursor Acute Lymphoblastic Leukemia(ALL)
Lead sponsor
Harbin Hematology and Oncology Institute
Phase
Observational
Overall status
Completed
Start date
July 10, 2015
Completion date
October 10, 2016
Enrollment
632 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b-precursor acute lymphoblastic leukemia